The future of clinical medicine: ten trends of development in critical care medicine

doi:10.3877/cma.j.jssn.2096-1537.2015.01.002

Abstract

Abstract:

Great progress in critical care medicine has been achieved in the last 40 years in china. Critical care medicine was established as a discipline and played a crucial role in the development of clinical medicine and practice. We should explore the right direction for development in critical care medicine in the future, establish a clear plan, clarify the ideas of development, provide high quality critical care, and keep the critical care medicine stand at the forefront of clinical medicine development.

Key words: Critical care medicine, Future, Development, Trend

Songqiao Liu, Hui Chen, Haibo Qiu. The future of clinical medicine: ten trends of development in critical care medicine[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2015, 01(01): 3-9.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.jssn.2096-1537.2015.01.002

https://icu.cma-cmc.com.cn/EN/Y2015/V01/I01/3

References 28

[1]	Jones DA, DeVita MA, Bellomo R. Rapid-response teams[J]. N Engl J Med, 2011, 365(2):139–146.
[2]	Angus DC, Kelley MA, Schmitz RJ, et al. Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: can we meet the requirements of an aging population?[J]. JAMA, 2000, 284(21):2762–2770.
[3]	Khunlertkit A, Carayon P. Contributions of tele-intensive care unit (Tele-ICU) technology to quality of care and patient safety[J]. J Crit Care, 2013, 28(3):315.e1–12.
[4]	Young LB, Chan PS, Lu X, et al. Impact of telemedicine intensive care unit coverage on patient outcomes: a systematic review and meta-analysis[J]. Arch Intern Med, 2011, 171(6):498–506.
[5]	Celi LA, Mark RG, Stone DJ, et al. ″Big data″ in the intensive care unit. Closing the data loop[J]. Am J Respir Crit Care Med, 2013, 187(11):1157–1160.
[6]	Pickering BW, Gajic O, Ahmed A, et al. Data utilization for medical decision making at the time of patient admission to ICU[J]. Crit Care Med, 2013, 41(6):1502–1510.
[7]	Murugan R. Movement towards personalised medicine in the ICU[J]. Lancet Respir Med, 2015, 3(1):10–12.
[8]	Wong HR, Cvijanovich NZ, Anas N, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock[J]. Am J Respir Crit Care Med, 2015, 191(3):309–315.
[9]	Flores C, Pino-Yanes Mdel M, Villar J. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury[J]. Crit Care, 2008, 12(5):R130.
[10]	Deans KJ, Minneci PC, Suffredini AF, et al. Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols[J]. Crit Care Med, 2007, 35(6):1509–1516.
[11]	Caironi P, Cressoni M, Chiumello D, et al. Lung opening and closing during ventilation of acute respiratory distress syndrome[J]. Am J Respir Crit Care Med. 2010. 181(6):578–586.
[12]	Leentjens J, Kox M, van der Hoeven JG, et al. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?[J]. Am J Respir Crit Care Med, 2013, 187(12):1287–1293.
[13]	Elseviers MM, Lins RL, Van der Niepen P, et al. Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury[J]. Crit Care, 2010, 14(6):R221.
[14]	Schneider AG, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis[J]. Intensive Care Med, 2013, 39(6):987–997.
[15]	Prowle JR, Bellomo R. Continuous renal replacement therapy: recent advances and future research[J]. Nat Rev Nephrol, 2010, 6(9):521–529.
[16]	Parikh K, Davis AB, Pavuluri P. Do we need this blood culture?[J]. Hosp Pediatr, 2014, 4(2):78–84.
[17]	Reuter S, Ellington MJ, Cartwright EJ, et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology[J]. JAMA Intern Med, 2013, 173(15):1397–1404.
[18]	Banerjee R, Teng CB, Cunningham SA, et al. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing[J]. Clin Infect Dis, 2015, 61(7):1071–1080.
[19]	Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care[J]. J Trauma Acute Care Surg, 2012, 72(6):1491–1501.
[20]	Del Sorbo L, Pisani L, Filippini C, et al. Extracorporeal Co2 removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control[J]. Crit Care Med, 2015, 43(1):120–127.
[21]	Hoeper MM, Wiesner O, Hadem J, et al. Extracorporeal membrane oxygenation instead of invasive mechanical ventilation in patients with acute respiratory distress syndrome[J]. Intensive Care Med, 2013, 39(11):2056–2057.
[22]	Nieman GF, Gatto LA, Bates JH, et al. Mechanical Ventilation as a Therapeutic Tool to Reduce ARDS Incidence[J]. Chest, 2015, 148(6):1396–1404.
[23]	Neto AS, Simonis FD, Barbas CS, et al. Lung-Protective Ventilation With Low Tidal Volumes and the Occurrence of Pulmonary Complications in Patients Without Acute Respiratory Distress Syndrome: A Systematic Review and Individual Patient Data Analysis[J]. Crit Care Med, 2015, 43(10):2155–2163.
[24]	Jacob KA, Leaf DE, Dieleman JM, et al. Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac Surgery[J]. J Am Soc Nephrol, 2015, 26(12):2947–2951.
[25]	Zarbock A, Schmidt C, Van Aken H, et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial[J]. JAMA, 2015, 313(21):2133–2141.
[26]	Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial[J]. Lancet Respir Med, 2015, 3(1):24–32.
[27]	Lee SG. Twenty-year survival post-liver transplant: challenges and lessons[J]. Hepatol Int, 2015, 9(3):342–5.
[28]	Hayanga AJ, Aboagye J, Esper S, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease[J]. J Thorac Cardiovasc Surg, 2015, 149(1):291–296.

Please choose a citation manager

Content to export